Diagnosis: Segmental vitiligo
A 28-year-old female presents with a unilateral depigmented patch on the right side of her face, following the trigeminal nerve distribution. The lesion has been stable for six months, with no associated symptoms. This case illustrates segmental vitiligo, highlighting typical clinical features and management strategies.
A 28-year-old female presents with a unilateral depigmented patch located on the right side of her face, corresponding to the trigeminal nerve distribution. The lesion has persisted for six months without any associated pruritus or discomfort. On examination, the depigmented patch is well-defined and lacks hair follicles.Location: Unilateral, following the trigeminal nerve distribution.Color: Completely depigmented, contrasting sharply with surrounding skin.Border: Well-defined, with no signs of inflammation.Hair: Depigmented hair may be present in the involved area.Associated symptoms: None; the patient reports no itching or pain.
The patient reports that the onset of the depigmented patch occurred approximately six months ago, with no identifiable triggers or preceding skin trauma. She has no significant past medical history and no family history of autoimmune diseases. The patient has not attempted any treatments for the lesion yet but expresses concern about its cosmetic appearance.Onset: Six months prior, with no preceding trauma or illness.Triggers: None identified; no known autoimmune conditions.Past medical history: Unremarkable; no chronic illnesses.Family history: Negative for vitiligo or autoimmune diseases.Social history: No significant stressors or lifestyle factors reported.
Acute / First-Line ManagementTopical corticosteroids, such as clobetasol propionate 0.05% ointment, applied twice daily to affected areas may be considered to reduce inflammation.Calcineurin inhibitors (e.g., tacrolimus ointment 0.1%) can be used as an alternative or adjunctive therapy, particularly for sensitive areas.Patient education regarding sun protection is essential to prevent sunburn and further contrast between affected and unaffected skin.Workup and Diagnostic ConfirmationClinical diagnosis based on history and physical examination is typically sufficient.Consider Wood's lamp examination to assess the extent of depigmentation and rule out other conditions.In cases of uncertainty, a skin biopsy may be performed to exclude other dermatoses.Long-Term ManagementRegular follow-up every 3-6 months to monitor for progression or new lesions.Phototherapy, such as narrowband UVB, may be considered for extensive involvement.Supportive therapy, including counseling and support groups, may benefit patients affected by the psychosocial impact of visible skin changes.
Post-inflammatory hypopigmentation: Often follows skin inflammation or trauma; the borders may be less defined, and there may be a history of prior injury.Idiopathic Guttate Hypomelanosis: Characterized by small, round, white spots, typically in sun-exposed areas; more common in older individuals.Pityriasis Alba: Common in children and adolescents; presents as lighter patches with mild scaling, often on the face and upper arms.Leukoderma of the Skin: Associated with systemic conditions or skin injuries that lead to localized loss of pigmentation.Albinism: Genetic condition leading to complete or partial lack of melanin, presenting at birth; involves the entire body rather than localized areas.Nevoid Basal Cell Carcinoma Syndrome: Can present with hypopigmented lesions but is accompanied by other systemic findings, including basal cell carcinomas.Incontinentia Pigmenti: A genetic disorder that can cause skin changes in a linear pattern; more common in females and associated with systemic issues.
High-Yield PearlsSegmental vitiligo: Typically presents as unilateral, stable depigmented patches, often in a dermatomal distribution.Triggers: Unlike generalized vitiligo, segmental vitiligo is less associated with autoimmune triggers and is more stable over time.Topical therapies: Clobetasol and tacrolimus are effective first-line treatments for localized vitiligo.Psychosocial impact: The visible nature of vitiligo can significantly affect a patient's quality of life, necessitating supportive care.Monitoring: Regular follow-up is essential to assess for disease progression or new lesion development.Segmental vitiligo is often stable and localized, making early recognition and management crucial for patient satisfaction.
Tags: vitiligo, segmental